Hologic Inc. ( HOLX) recently launched the next-generation NovaSure 6mm global endometrial ablation (GEA) system in an effort to expand in the growing GYN Surgical market. This next-generation ...
NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients The pivotal study ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
MARLBOROUGH, Mass., Nov. 14, 2016 /CNW/ -- Hologic, Inc. (Nasdaq: HOLX) today announced the launch of its next-generation NovaSure ® 6mm global endometrial ablation (GEA) system, the NovaSure ® ...
MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
BEDFORD, Mass., Nov. 19, 2014 /PRNewswire/ -- Hologic, Inc. , today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The NovaSure system is designed ...
MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced the launch of its next-generation NovaSure ® 6mm global endometrial ablation (GEA) system, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback